Compare Agora Inc (API) vs Merck & Co., Inc. (MRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agora Inc vs Merck & Co., Inc. — how do they compare? Agora Inc trades at $4.65 (market cap $385.97M), while Merck & Co., Inc. trades at $130.11 (market cap $323.00B). The key difference: Merck & Co., Inc. is far larger — about 836.9× Agora Inc's market cap, and Merck & Co., Inc. pays a 2.6% dividend while Agora Inc pays none. Which is the better fit depends on your goals.
| API | MRK | |
|---|---|---|
Market Cap | $385.97M | $323.00B |
Sector | Technology | Health |
52-Week High | $5.26 | $131.84 |
52-Week Low | $3.24 | $77.60 |
Enterprise Value | $138.95M | $369.77B |
Dividend Yield | — | 2.6% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agora, Inc. (API) trades at $4.46, up 7.47% today, with a bullish technical signal driven by moving averages. The company reported Q1 2026 EPS of $0.01, beating expectations, and shows improving fundamentals with 2025 revenue of $141.06M and net income of $9.53M. Recent news highlights its Q2 2026 earnings report scheduled for August 13, 2026.
Outlook is positive with analyst consensus at 60% buy, supported by a low P/B of 0.68 and strong cash flow growth. Risks include high P/E of 50.68 and competitive pressures in AI technology. The stock offers value potential if earnings growth continues, but volatility may persist near-term.
Merck (MRK) trades at $130.41, up 1.43% today, with a bullish technical outlook supported by moving averages and a consensus price target of $139.90. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $2.27. Revenue grew to $65.01B in 2025, and net income reached $18.25B, though 2026 projections show a decline. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, reflecting strategic growth initiatives.
The stock presents a favorable risk-reward profile with analyst support (67.57% buy ratings) and institutional accumulation, but faces risks from patent expirations, competitive pressures, and macroeconomic volatility. Earnings sustainability and integration of acquisitions are key to maintaining momentum amid a high P/E ratio of 104.74.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agora Inc
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.
Read more on API →About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →
